EMCDDA Home
  • EN
Search

Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2011 or most recent year available

Part (iii) New clients by country and rates of injection of primary drug (%)

CountryYearOpioids % InjectingCocaine % Injecting Amphetamines% injecting Total % Injecting
Belgium1201116.41.25.03.4
Bulgaria201184.20.00.078.7
Czech Republic201183.10.071.958.2
Denmark201123.00.00.01.5
Germany2201133.28.70.76.3
Estonia201184.0:50.069.9
Ireland201022.90.46.39.0
Greece201138.710.10.028.9
Spain201010.21.40.62.5
France201112.34.4:2.6
Italy3201150.54.10.022.6
Cyprus201146.80.00.05.0
Latvia4201188.40.053.944.6
Lithuania5201198.6:60.084.9
Luxembourg2011::::
Hungary201149.30.019.24.3
Malta201159.017.6:32.2
Netherlands201116.00.01.01.0
Austria201126.83.02.211.8
Poland6201046.2:8.49.0
Portugal7201113.11.00.06.8
Romania201190.25.90.041.8
Slovenia201149.725.0:38.2
Slovakia201163.10.025.424.8
Finland201166.70.064.337.2
Sweden2011::::
United Kingdom8201029.21.016.012.6
Croatia201153.33.60.015.9
Turkey201148.04.00.031.5
Norway2011::::
Total:33.62.625.012.0
 

Notes:

: Indicates no data available

Drug specific percentages are of clients whose primary drug and usual route of administration is known. Total % Injecting includes cases where primary drug is unknown or missing. Caution should be made when comparing the Total % Injecting with the % Injecting for Opioids, Cocaine and Amphetamines. For more information on the number of not known / missing cases for primary drug please see tables TDI-05 part 1 and TDI-05 part 2

Injecting as a route of administration is not reported for ecstasy, cannabis and other drugs.

(1) In Belgium if the exact primary drug is not known, the generic category is recorded.

(2) Amphetamines refer to stimulants in general. Data on route of administration refer to primary and non primary drugs.

(3) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(4) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(5) Amphetamines refer to stimulants in general.

(6) Category 'heroin' includes both heroin (brown and rarely appearing white) and so called 'kompot' (heroin gained from the poppy straws) still often used at the drug scene. The Polish TDI system has separate categories for heroin and 'kompot'. Additionally category 'amphetamines' includes both amphetamine and methamphetamine which are separate categories in Polish TDI.

(7) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 onwards data with previous years.

(8) Data are from 1st of April 2010 to 31st March 2011.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2012 — TDI tables V. 1.0-2011 See Table TDI-0 for details on sources.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013